Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities

Jayapriya B; Lourdu Jafrin Antony; Balamurugan P V; Dinesh Raja A

doi:10.5455/njppp.2021.11.07220202105072021

2024, Vol: 14, Issue: 4

14 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
15 / 07 / 2021

Natl J Physiol Pharm Pharmacol. 2021; 11(8): 920-924

doi: 10.5455/njppp.2021.11.07220202105072021

Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities

Jayapriya B, Lourdu Jafrin Antony, Balamurugan P V, Dinesh Raja A.

Abstract
Background: Tuberculosis (TB) is one of the common infectious diseases in India with a high socioeconomic impact. It is estimated that more than 5% of the patients on antitubercular drugs develop adverse drug reactions (ADRs) and subsequently this proportion is expected to increase with comorbidities due to drug-disease interactions and also drug-drug interactions used to treat the comorbidities.

Aims and Objectives: This study aims to assess the prevalence and pattern of ADRs due to antitubercular therapy in TB patients with comorbidities and risk factors.

Materials and Methods: Fifty TB patients were enrolled, their sociodemographic data, concurrent diseases, and medications other than antitubercular agents that the patients might be taking were investigated. Any adverse reaction and the steps taken toward the management of adverse reaction were immediately noted on the Suspected ADR Reporting Form. The severity of ADRs was assessed using the Naranjo scale and WHO causality assessment scale.

Results: Out of 50 patients, 10 ADRs were reported, out of which seven ADRs were reported by males and two were reported by females (P > 0.05). All ADRs were from patients with pulmonary TB. The most common ADRs were gastrointestinal problems such as loss of appetite, symptoms suggestive of gastritis such as heart burns and abdominal pain. About 50% of the patients who developed ADR had diabetes as comorbidity (χ2 = 0.5208, P > 0.05) and all were having diabetes for more than 5 years duration.

Conclusion: Most common comorbid condition with TB was found to be combined diabetes and hypertension.

Key words: Adverse Drug Reaction; Antitubercular Drugs; Comorbidities; Diabetes; Smokers

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Jayapriya B Articles by Lourdu Jafrin Antony Articles by Balamurugan P V Articles by Dinesh Raja A
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

B J, Antony LJ, V BP, A DR. Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. Natl J Physiol Pharm Pharmacol. 2021; 11(8): 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Web Style

B J, Antony LJ, V BP, A DR. Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. https://www.njppp.com/?mno=90762 [Access: March 14, 2024]. doi:10.5455/njppp.2021.11.07220202105072021

AMA (American Medical Association) Style

B J, Antony LJ, V BP, A DR. Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. Natl J Physiol Pharm Pharmacol. 2021; 11(8): 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Vancouver/ICMJE Style

B J, Antony LJ, V BP, A DR. Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. Natl J Physiol Pharm Pharmacol. (2021), [cited March 14, 2024]; 11(8): 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Harvard Style

B, J., Antony, . L. J., V, . B. P. & A, . D. R. (2021) Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. Natl J Physiol Pharm Pharmacol, 11 (8), 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Turabian Style

B, Jayapriya, Lourdu Jafrin Antony, Balamurugan P V, and Dinesh Raja A. 2021. Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. National Journal of Physiology, Pharmacy and Pharmacology, 11 (8), 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Chicago Style

B, Jayapriya, Lourdu Jafrin Antony, Balamurugan P V, and Dinesh Raja A. "Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 920-924. doi:10.5455/njppp.2021.11.07220202105072021

MLA (The Modern Language Association) Style

B, Jayapriya, Lourdu Jafrin Antony, Balamurugan P V, and Dinesh Raja A. "Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities." National Journal of Physiology, Pharmacy and Pharmacology 11.8 (2021), 920-924. Print. doi:10.5455/njppp.2021.11.07220202105072021

APA (American Psychological Association) Style

B, J., Antony, . L. J., V, . B. P. & A, . D. R. (2021) Pattern of adverse drug reactions of antitubercular drugs in tuberculosis patients with comorbidities and risk factors in South Indian government health-care facilities. National Journal of Physiology, Pharmacy and Pharmacology, 11 (8), 920-924. doi:10.5455/njppp.2021.11.07220202105072021

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272